Aug 25, 2016
This secondary analysis of a randomized clinical trial assesses the effect of pharmacologic therapy and clinical risk factors on incident conduction system disease in patients with hypertension.Proceed to the page: http://linkis.com/GZhCY
Research from JAMA Cardiology — Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine — A Secondary Analysis of a Randomized Clinical Trial
Lisinopril therapy significantly reduces incident conduction system disease, indicates a post-hoc analysis of ALLHAT data.
This randomized clinical trial compares the effects of high-flow nasal cannula oxygen therapy vs conventional oxygen therapy on risk of reintubation among mechanically ventilated patients at low risk for reintubation.
Research from JAMA — Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury — The ELAIN Randomized Clinical Trial
This randomized clinical trial compares the effectiveness and safety of bilateral endobronchial coil treatment vs usual care for improving exercise tolerance among patients with emphysema and severe lung hyperinflation.
There are three types of benzodiazepine abuse. The abuse case could be either pharmacological, self-prescribed, or recreational. Thus, everyone is at risk of ..
Further bipolar disorder and substance abuse statistics show that for any given 12 months, 2.6 percent of adults in America have had a case of bipolar disorder..
Economic and development analysis: Perspectives on economics, society, development, freedom & social justice. Leading issues in Oromo, Oromia, Africa & world affairs. Oromo News. African News. world News. Views. Formerly Oromia Quarterly
Here to give our two cents about C-Ent.
Instant Payouts. Regular Free Spin Offers at 32Red Online Casino. Sign up to 32Red.com for the best bonuses, frequent special offers and one of the largest selections of casino games.
is a in the HuntingNet.com Forums. View 's profile.